EMA — authorised 19 December 2014
- Marketing authorisation holder: Eli Lilly Nederland B.V.
- Status: approved
🇪🇺 Cyramza in European Union
EMA authorised Cyramza on 19 December 2014
Marketing authorisation
Cyramza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Cyramza approved in European Union?
Yes. EMA authorised it on 19 December 2014.
Who is the marketing authorisation holder for Cyramza in European Union?
Eli Lilly Nederland B.V. holds the EU marketing authorisation.